Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS), Twist Bioscience (TWST) and Catalent (CTLT)
Catalent Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Alnylam Pharma (ALNY) and Catalent (CTLT)
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), BeiGene (BGNE) and Catalent (CTLT)
Catalent (CTLT) Gets a Hold From Barclays
Analyst Maintains Hold Rating Amid Catalent's Strategic Acquisition and Complex Valuation
Stephens & Co. Downgrades Catalent to Equal-Weight, Announces $63.5 Price Target
Catalent Analyst Ratings
Barclays Sticks to Their Hold Rating for Catalent (CTLT)
Analysts' Top Healthcare Picks: Hookipa Pharma (HOOK), Catalent (CTLT)
RBC Raises Price Target on Catalent to $58 From $55 on Increased Confidence in Achievability of Estimates; Outperform Kept
Catalent Analyst Ratings
Strong Buy Rating for Catalent Backed by Growth in Biopharma Contracting and Robust Pipeline
Deutsche Bank Adjusts Catalent Price Target to $44 From $48, Maintains Hold Rating
Baird Upgrades Catalent to Outperform, Cites Confidence in New CFO
Wells Fargo Maintains Equal-Weight on Catalent, Lowers Price Target to $42
What 9 Analyst Ratings Have To Say About Catalent
RBC Trims Price Target on Catalent to $55 From $58, Keeps Outperform Rating
Hold Rating on Catalent's Stock: Balancing Recurring Revenue Prospects With Challenges in Biologics Sector
Analysts' Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Catalent (CTLT)
No Data